Rock Springs Capital Management LP Aura Biosciences, Inc. Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$8.97 - $12.38 $2.66 Million - $3.68 Million	-296,861 Reduced 29.11%	722,896 $6.48 Million
Q4 2022 Feb 14, 2023	BUY	$9.86 - $14.59 $39,440 - $58,360	4,000 Added 0.39%	1,019,757 $10.7 Million
Q3 2022 Nov 14, 2022	BUY	$13.1 - $20.34 $90,953 - $141,220	6,943 Added 0.69%	1,015,757 $18.4 Million
Q2 2022 Aug 15, 2022	BUY	$12.37 - $21.86 $8,659 - $15,302	700 Added 0.07%	1,008,814 $14.3 Million
Q4 2021 Feb 14, 2022	BUY	$14.76 - $24.89 $14.9 Million - $25.1 Million	1,008,114 New	1,008,114 $17.1 Million

37.6M

122K

38.5K

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $268M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.